Loading...

APGE APOGEE THERAPEUTICS INC Earnings Reports 8-K Filing

PG T

PG

APOGEE THERAPEUTICS INC

(APGE)

2025 8-K

Earnings Announcement

Stock Offering Announcement

Product Expansion

Clinical Trials

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Clinical Trial Update

Clinical Trial Launch

Financial Results

Meeting Results

Appointment of Director

Earnings Report

Presentation of Phase 1 Data

Financial Results and Phase...

Financial Results Announcement

Appointment of Mark C. McKe...

External Links:

On November 10, 2025, Apogee Therapeutics, Inc. reported positive interim Phase 1 results for drug APG333 and announced financial results for the quarter ending September 30, 2025.

AI Assistant

APOGEE THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.